Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Colestipol hydrochloride
Drug ID BADD_D00522
Description Bile acid sequestrants like colestipol have been in use since the 1970s.[FDA Label, F4555, F4567, L6262] And even though such an agent may very well be useful in reducing elevated cholesterol levels and decreasing the risk for atherosclerotic vascular disease due to hypercholesterolemia, colestipol is still generally only employed as an adjunct therapy and the relatively physical nature of its pharmacological activity sometimes limits its usefulness.[FDA Label, F4555, F4567, L6262] In particular, as colestipol's general mechanism of action ultimately results in the decreased absorption and enhanced secretion of bile acids and lipids in the feces, patients who take complicated medication regimens, experience constipation or biliary obstruction, etc. may not be good candidates for using the agent owing to its physical effects on the gut.[FDA Label, F4555, F4567, L6262] Alternatively, colestipol predominantly elicits its activities within the gut environment because it undergoes little absorption and metabolism.[FDA Label, F4555, F4567, L6262] The resultant lack of systemic exposure consequently means the medication generally demonstrates very few adverse effects inside the body.[FDA Label, F4555, F4567, L6262]
Indications and Usage For use, as adjunctive therapy to diet, for the reduction of elevated serum total and LDL-C in patients with primary hypercholesterolemia (elevated LDL-C) who do not respond adequately to diet.
Marketing Status Prescription
ATC Code C10AC02
DrugBank ID DB00375
KEGG ID D02113
MeSH ID D003084
PubChem ID 3084661
TTD Drug ID D0GJ8R
NDC Product Code 0009-0450; 59762-0450; 11014-0125; 0009-0370; 58159-060; 0115-2142; 66499-0007; 72643-019; 59762-0260; 11014-0126; 0115-5211; 0115-5213; 0115-5212; 66406-0109; 0009-0260; 70518-2693; 43826-140
Synonyms Colestipol | Colestipol Hydrochloride | Hydrochloride, Colestipol | Colestipol HCl | HCl, Colestipol | U-26,597 A | U 26,597 A | U26,597 A | Colestid
Chemical Information
Molecular Formula C8H24ClN5
CAS Registry Number 4961-41-5
SMILES C(CNCCNCCNCCN)N.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Alanine aminotransferase increased13.03.01.003--
Angina pectoris24.04.04.002; 02.02.02.002--
Arthralgia15.01.02.001--
Arthritis15.01.01.001--
Aspartate aminotransferase increased13.03.01.006--
Asthenia08.01.01.001--Not Available
Back pain15.03.04.005--
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.011--Not Available
Cholecystitis09.03.01.001--
Cholelithiasis09.03.01.002--Not Available
Constipation07.02.02.001--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dyspepsia07.01.02.001--
Dysphagia07.01.06.003--
Dyspnoea22.02.01.004; 02.01.03.002--
Fatigue08.01.01.002--
Flatulence07.01.04.002--
Haematochezia24.07.02.012; 07.12.02.003--Not Available
Headache17.14.01.001--
Insomnia19.02.01.002; 17.15.03.002--
Migraine24.03.05.003; 17.14.02.001--Not Available
Musculoskeletal pain15.03.04.007--
Oesophageal obstruction07.13.02.002--
Pain in extremity15.03.04.010--
Peptic ulcer07.04.07.001--Not Available
Rash23.03.13.001--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages